Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
BlueOcean Ventures SA is a venture capital firm founded in 2020 by Faris Sabeti, Emmanuel de Watteville, Sacha Haymoz, and Thomas Zehnder. The firm is registered in Jersey as an investment fund and operates from its headquarters in Geneva, Switzerland. BlueOcean Ventures specializes in early-stage investments, particularly in medical device and life science companies that are often overlooked in traditional funding circles.
The firm has established a strong presence in the European market, focusing on startups that demonstrate significant growth potential in untapped sectors. With a portfolio of 12 companies, BlueOcean Ventures has positioned itself as a key player in the early-stage investment landscape, particularly in Switzerland and surrounding regions.
As of now, the firm has a total assets under management (AUM) that reflects its commitment to supporting innovative healthcare solutions. BlueOcean Ventures aims to leverage its extensive network of industry experts to provide valuable insights and resources to its portfolio companies, enhancing their chances of success in competitive markets.
BlueOcean Ventures primarily targets early-stage medical device and diagnostics companies in Switzerland and Europe. The firm is particularly interested in startups that operate within the biotech, healthcare, digital health, and nanotechnology sectors. BlueOcean Ventures typically invests in companies with pre-money valuations ranging from CHF 3 to 10 million, allowing them to act as lead investors or co-investors in significant funding rounds.
The firm seeks to identify and support highly promising startups that demonstrate innovative solutions and significant growth potential. BlueOcean Ventures emphasizes the importance of a strong founding team and a clear market strategy when evaluating investment opportunities. Their investment strategy is designed to foster long-term partnerships with portfolio companies, providing not only capital but also strategic guidance and access to a network of industry experts.
BlueOcean Ventures has built a diverse portfolio of 12 companies, each contributing to advancements in medical technology and life sciences. Notable portfolio companies include:
This portfolio reflects BlueOcean Ventures' commitment to supporting groundbreaking innovations in healthcare and medical technology.
Faris Sabeti: Co-Founder and Advisor at BlueOcean Ventures, Faris has extensive experience in venture capital and healthcare investments. He has a strong background in identifying promising startups and guiding them through the investment process.
Emmanuel de Watteville: Co-Founder and Advisor, Emmanuel brings a wealth of knowledge in medical technology and investment strategies. His expertise helps shape the firm's investment focus and portfolio management.
Sacha Haymoz: Advisor at BlueOcean Ventures, Sacha has a background in entrepreneurship and innovation in the healthcare sector. He plays a key role in evaluating potential investments and supporting portfolio companies.
Thomas Zehnder: Co-Founder and Advisor, Thomas has a strong track record in venture capital and a deep understanding of the medical device market. His insights are invaluable in guiding the firm's investment decisions.
To pitch BlueOcean Ventures, founders should visit their website and submit a detailed pitch deck. The deck should include information about the business model, market opportunity, competitive landscape, and the founding team. A warm introduction is preferred but not mandatory. Founders can expect a response within a few weeks after submission.
In 2023, BlueOcean Ventures announced its latest investment in **Mikajaki SA**, a company focused on innovative cyanide monitoring solutions. This investment aligns with the firm's strategy of supporting early-stage medical device companies.
Additionally, BlueOcean Ventures has been actively engaging with its portfolio companies, providing strategic guidance and resources to enhance their growth potential. The firm continues to explore new investment opportunities within the biotech and healthcare sectors across Europe.
What investment criteria does BlueOcean Ventures look for?
BlueOcean Ventures focuses on early-stage medical device and diagnostics companies with pre-money valuations between CHF 3 to 10 million. They prioritize startups that demonstrate innovative solutions and significant growth potential in the biotech, healthcare, digital health, and nanotechnology sectors.
How can I pitch to BlueOcean Ventures?
Founders can submit their pitches through the official website of BlueOcean Ventures. It is recommended to include a detailed business plan, market analysis, and information about the founding team in the pitch deck.
What makes BlueOcean Ventures different from other investors?
BlueOcean Ventures distinguishes itself by focusing specifically on early-stage investments in medical devices and life sciences, particularly in untapped markets. Their strong emphasis on leading or co-investing in significant funding rounds allows them to provide substantial support to their portfolio companies.
What is the geographic scope of BlueOcean Ventures?
The firm primarily invests in Switzerland and Europe, targeting startups that are positioned to make a significant impact in the healthcare sector.
What kind of post-investment involvement can founders expect?
BlueOcean Ventures aims to provide ongoing support to its portfolio companies through access to a network of industry experts, strategic guidance, and potential follow-on investments to help them scale effectively.
What is the typical check size for investments?
BlueOcean Ventures typically invests in early-stage companies with pre-money valuations ranging from CHF 3 to 10 million, allowing for substantial investment amounts as lead or co-investor.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.